Drug ID: | NPD6790 |
Drug Name: | SCIO-323 |
Molecular Formula: | C27H30FN3O4 |
Canonical SMILES: | COc1cc2n(C)cc(c2cc1C(=O)N1CCC(CC1)Cc1ccc(cc1)F)C(=O)C(=O)N(C)C |
Standard InCHI: | InChI=1S/C27H30FN3O4/c1-29(2)27(34)25(32)22-16-30(3)23-15-24(35-4)21(14-20(22)23)26(33)31-11-9-18(10-12-31)13-17-5-7-19(28)8-6-17/h5-8,14-16,18H,9-13H2,1-4H3 |
Standard InCHIKey: | JBNWDYGOTHQHOZ-UHFFFAOYSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DIB002432 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | |
ChEBI | |
CAS Number |
Molecular Weight | 479.22 |
ALogP | -1.3231 |
MLogP | 3.55 |
XLogP | 3.778 |
HDA | 6 |
HBD | 0 |
Rotatable Bonds | 13 |
TPSA | 71.85 |
RO5 Violation | 0 |